Tech Company Financing Transactions
Octozi Funding Round
Octozi, operating out of Brooklyn, secured $3 million from Surface Ventures, Debiopharm Diagnostics and Remarkable Ventures.
Transaction Overview
Company Name
Announced On
7/7/2026
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
370 Jay St
Brooklyn, NY 11201
USA
Brooklyn, NY 11201
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Octozi helps the pharma industry accelerate drug approvals with AI agents. Over $100 billion is spent on clinical development and thousands of hours of manual work goes into creating documentation, cleaning, and analyzing the data required for regulatory submission. Our AI-augmented platform automates processes involved in data cleaning and review, decreasing the time needed for database lock while enhancing data quality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amit Patel
Browse more venture capital transactions:
Prev: 7/7/2026: Pediatrica Health venture capital transaction
Next: 7/7/2026: Bizay venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs